All News

Michael Barr, MD, MBA, MACP, FRCP, discusses the importance of physicians and pharmacists sharing skills to increase positive patient outcomes.

Farah Towfic, PharmD, MBA, RPh, director, CEO Operations, US Pharmacopeia, details some of the moments that led her to the pharmacy field and the important role that mentorship played in that process.

Rucaparib is the only PARP inhibitor demonstrated to have better outcomes than a docetaxel-containing control arm, according to researchers.

There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.

QR codes are currently used in various health care settings, such as in hospitals for patient verification, but more recently for health care-related education.

Tirzepatide received Fast Track designation from the FDA after showing superiority to placebo in treating obesity in clinical trials.

The discovery of a protective antiviral protein complex could help researchers find new ways to combat hepatitis B virus.

The pharmacologic options for irritable bowel syndrome are based on the adverse effect profile, cost, and predominant symptoms.

New research suggests that acetazolamide and standard loop-diuretic therapy may decrease congestion and prevent future hospitalizations in patients with acute decompensated heart failure.

For patients facing end-of-life care, psychedelic medicines may offer a chance to feel connected with themselves and others during such a difficult time.

New research suggests that psychedelics, and specifically ketamine, can increase neuroplasticity to help a patient with an eating disorder get “unstuck,” and help treat the disorder better than psychotherapy alone.

Prior evidence regarding the safety and efficacy of the combination of apremilast and phototherapy was lacking, prompting researchers to investigate further.

Antioxidants are capable of converting highly destructive free radicals and nonradical molecules, thereby reducing cerebral stress.

Researchers identified a new immunotherapeutic target that may be effectively treated with CAR T-cell therapy in patients with pretreated multiple myeloma.

Results from the largest head-to-head trial of programmed death receptor-1 inhibitors suggest that dostarlimab and chemotherapy could be an effective treatment option for patients with metastatic non-squamous non-small cell lung cancer.

High intake of refined grains linked to an increased risk of premature coronary artery disease.

Higher C-reactive protein levels have been linked to cognition problems among older breast cancer survivors.

Study finds cardioprotective medications were used in approximately 11% more men than women with type 1 diabetes.

Having a platform like Neil in a university to combat equity, diversity, and other measures in the public health space is a unique benefit as a pharmacist.

Two Houston Methodist cancer researchers were granted a quarter-million dollars each to study some of the most lethal forms cancer, including triple-negative breast cancer and multiple myeloma.

Yvonne Chen, PhD, discusses some of the strategies that researchers are using to improve T-cell effectiveness and overcome immunosuppression in CAR T-cell therapy.

Vaccines reduce the risk of COVID-19 infection and hospitalization, but a recent study suggests that misinformation could make adults hesitant to vaccinate children 5 to 11 years of age.

A large collective of researchers may be one step closer to developing a vaccine against HIV after engineering a protein that triggers a widespread antibody response.

The American College of Chest Physicians' update of its CHEST guidelines for the treatment of VTE includes 29 guidance statements.

Women with a history of gestational diabetes had a 45% increased risk of overall cardiovascular and cerebrovascular diseases.

Aflibercept 8 mg demonstrated non-inferiority in vision gains in both the 12- and 16-week dosing regimens.

Dispensing naloxone provides an example of how small changes can make a significant difference.

Lisa Schwartz, PharmD, RPh, senior director of Professional Affairs at NCPA, discusses the Drug Supply Chain Security Act and why it was updated for the distribution of naloxone.

Currently available agents may reduce the need for stem cell transplantation in patients with acute lymphocytic leukemia.

Loosened restrictions will likely create a more pronounced influenza season this fall.